Legislation
Background
Bipartisan Consensus
Consequences
Advocacy
100

The PDPRA targets to improve a benefit that is part of this federal health coverage program?

Medicare

100

How many Americans say they have difficulty affording their prescriptions?

1 in 4

100

What are economic Forces that protect the taxpayer and Medicare?

“True Market Forces”

100

What groups of people would this Act not benefit?

Consumers with employer sponsored health insurance, low income patients, hospitals

100

Three groups of people most directly impacted by PDPRA who were at the forefront of advocacy campaigns

Patients, pharmacists, and physicians

200

The PDPRA legislation will fight against pay-for-delay settlements,, a technique used to try to keep ___ (lower-cost) drugs off pharmacy shelves.

Generic

200

How much does the average American spend on prescription drugs per year?

$1,200

200

What is an industry or system rife with gaming, in which profits are regularly prioritized over patients?

“Big Pharma” or the Pharmaceutical Industry in America

200

What do people say is "the only real answer to lowering drug prices"?

"genuine price cuts come from competition"

200

The primary concern for the patients and commendation for the committee

Transparency

300

The PDPRA establishes a new out-of-pocket cap on drug spending of how many U.S. dollars?

$3,100.

300

In general, what kind of prescription drug costs the most?

Treatment for rare diseases

300

What is President Trump’s opinion on This issue?

“Pfizer and other drug companies should be ashamed that they have raised drug prices for no reason. They are merely taking advantage of the poor and others unable to defend themselves, while at the same time giving bargain basement prices to other countries in Europe and elsewhere. We will respond!”

300

Section 107: "Medicare Part B Rebate by Manufacturers for Drugs or Biologicals with Prices Increasing Faster than Inflation" will prohibit?

Health and Human Services from making Medicare payment available under Part B.

300

Organization that has spearheaded efforts to “ improve medication use and enhance patient safety”?

ASHP (American Society of Health-System Pharmacists)

400

The United States is responsible for about ____ percent of all worldwide pharmaceutical profit? 

64-78 percent

400

What is the main reason prescription drug prices are rising?

Little to no competition in prices

400

What is the strategic incentivization of PBM’s (Pharmacy Benefits Managers) to stay out of “catastrophic level” and negotiate the best deal for the taxpayers?

PDPRA’s important changes to the structure of the Part D program

400

This Act would ________ payment to off-campus facilities, having a potentially negative impact on community care.

Reduce

400

Two groups of people advocates work with to achieve medication affordability

Like-minded stakeholders and members of Congress

500

The PDPRA’s goal is to address the issues of the current prescription drug system in the United States. Americans worry that the system has created incentives for middlemen, also called _____(hint: acronym PBM), to complicate the drug pricing process and increase their own profits.

Pharmacy-Benefit Managers

500

True or False: 60% of prescriptions filled in the U.S. are generic drugs

False. Approximately 90% of prescriptions filled are generic.

500

What are “Gimmicks and Price Increases”?

A practice where pharmaceutical companies make minor changes to existing drugs to gain additional market exclusivity, where no major scientific innovation/exclusivity is justified

500

What are some of the unhealthy ways people are cutting down on their prescription prices?

Cutting pills in half, skipping doses, not filling prescriptions in the first place

500

Organization concerned with the PDPRA’s implementation of “payment reductions to hospitals and physicians [that] do not address the high prices set by drug companies”

AHA (American Hospital Association)

M
e
n
u